 |
XyloCor Therapeutics
Last updated: September 01, 2025
CEO Albert Gianchetti
USA | Funding: $107.1M (+)
Website: https://xylocor.com/
XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease.
Website: https://xylocor.com/
XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease.
